ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,793,166 | -13.3% | 565,891 | -0.3% | 0.00% | 0.0% |
| Q2 2023 | $13,600,540 | +26.3% | 567,872 | -0.8% | 0.00% | +50.0% |
| Q1 2023 | $10,768,244 | +15.7% | 572,170 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $9,308,616 | +7.0% | 584,712 | +10.0% | 0.00% | 0.0% |
| Q3 2022 | $8,696,000 | +24.7% | 531,517 | +7.4% | 0.00% | 0.0% |
| Q2 2022 | $6,973,000 | -43.5% | 494,809 | -2.9% | 0.00% | 0.0% |
| Q1 2022 | $12,346,000 | +0.7% | 509,789 | -3.0% | 0.00% | 0.0% |
| Q4 2021 | $12,260,000 | +41.6% | 525,328 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $8,659,000 | -29.1% | 521,277 | +4.1% | 0.00% | 0.0% |
| Q2 2021 | $12,214,000 | +10.0% | 500,804 | +16.3% | 0.00% | 0.0% |
| Q1 2021 | $11,108,000 | -56.5% | 430,523 | -9.8% | 0.00% | -66.7% |
| Q4 2020 | $25,510,000 | +51.1% | 477,176 | +16.6% | 0.01% | +50.0% |
| Q3 2020 | $16,884,000 | -18.2% | 409,328 | -3.9% | 0.00% | -33.3% |
| Q2 2020 | $20,652,000 | -3.5% | 426,083 | -15.9% | 0.01% | -14.3% |
| Q1 2020 | $21,404,000 | -5.1% | 506,604 | -3.9% | 0.01% | +16.7% |
| Q4 2019 | $22,560,000 | +25.9% | 527,360 | +5.9% | 0.01% | +20.0% |
| Q3 2019 | $17,917,000 | +40.6% | 497,815 | +4.4% | 0.01% | +66.7% |
| Q2 2019 | $12,743,000 | -6.9% | 476,710 | -6.5% | 0.00% | -25.0% |
| Q1 2019 | $13,694,000 | +73.5% | 510,013 | +4.5% | 0.00% | +100.0% |
| Q4 2018 | $7,892,000 | -20.9% | 488,076 | +1.6% | 0.00% | -33.3% |
| Q3 2018 | $9,972,000 | +48.2% | 480,326 | +9.0% | 0.00% | +50.0% |
| Q2 2018 | $6,731,000 | -27.8% | 440,808 | +6.2% | 0.00% | -33.3% |
| Q1 2018 | $9,326,000 | -32.2% | 415,040 | -9.1% | 0.00% | -25.0% |
| Q4 2017 | $13,746,000 | -19.4% | 456,482 | +0.8% | 0.00% | -20.0% |
| Q3 2017 | $17,053,000 | +45.5% | 452,696 | +7.7% | 0.01% | +66.7% |
| Q2 2017 | $11,722,000 | -14.0% | 420,278 | +6.0% | 0.00% | -25.0% |
| Q1 2017 | $13,636,000 | +25.9% | 396,646 | +5.6% | 0.00% | +33.3% |
| Q4 2016 | $10,827,000 | -6.3% | 375,455 | +3.4% | 0.00% | 0.0% |
| Q3 2016 | $11,552,000 | -12.1% | 363,200 | -10.3% | 0.00% | -25.0% |
| Q2 2016 | $13,144,000 | +10.0% | 404,944 | -5.2% | 0.00% | 0.0% |
| Q1 2016 | $11,945,000 | -58.9% | 427,225 | -47.6% | 0.00% | -55.6% |
| Q4 2015 | $29,043,000 | -17.0% | 814,679 | -23.0% | 0.01% | -18.2% |
| Q3 2015 | $35,006,000 | -17.3% | 1,058,567 | +4.7% | 0.01% | -8.3% |
| Q2 2015 | $42,348,000 | +11.3% | 1,011,208 | -13.4% | 0.01% | +20.0% |
| Q1 2015 | $38,035,000 | -37.3% | 1,167,064 | -38.9% | 0.01% | -37.5% |
| Q4 2014 | $60,678,000 | +11.3% | 1,911,140 | -13.2% | 0.02% | +6.7% |
| Q3 2014 | $54,509,000 | +177.5% | 2,201,449 | +153.2% | 0.02% | +400.0% |
| Q2 2014 | $19,642,000 | +82.8% | 869,458 | +96.9% | 0.00% | 0.0% |
| Q1 2014 | $10,744,000 | +1.6% | 441,595 | +4.4% | 0.00% | 0.0% |
| Q4 2013 | $10,570,000 | -54.2% | 422,999 | -49.7% | 0.00% | 0.0% |
| Q3 2013 | $23,094,000 | +215.9% | 840,618 | +108.7% | 0.00% | +50.0% |
| Q2 2013 | $7,310,000 | – | 402,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |